Uptake of population-based flexible sigmoidoscopy screening for colorectal cancer: A nurse-led feasibility study

Journal of Medical Screening

Volumn 14, Issue 2, 2007, Pages 76-80

  Brotherstone, Hannah ^b   Vance, Maggie ^a   Edwards, Robert ^c   Miles, Anne ^d   Robb, Kathryn A ^d   Evans, Ruth E C ^d   Wardle, Jane ^e   Atkin, Wendy ^a  

^a ST MARK S HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^d UCL

^e IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER SCREENING; COLORECTAL CANCER; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEASIBILITY STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NURSE; SIGMOIDOSCOPY; UNITED KINGDOM;

COLORECTAL NEOPLASMS; FEASIBILITY STUDIES; FEMALE; GREAT BRITAIN; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; NURSE'S ROLE; NURSES; PATIENT ACCEPTANCE OF HEALTH CARE; PILOT PROJECTS; SIGMOIDOSCOPY;

EID: 34447536827     PISSN: 09691413     EISSN: 14755793     Source Type: Journal    
DOI: 10.1258/096914107781261972     Document Type: Article

References (40)

1. Cancer research UK. Bowel (colorectal) cancer: the incidence of bowel cancer in the UK. http://info.cancerresearchuk.org/cancerstats/types/ bowel/2007
2. Ciccolallo L, Capocaccia R, Coleman MP, et al. Survival differences between European and US patients with colorectal cancer: role of stage at diagnosis and surgery. Gut 2005;54:268-73
3. Gatta G, Capocaccia R, Sant M, et al. Understanding variations in survival for colorectal cancer in Europe: a EUROCARE high resolution study. Gut 2000;47:533-8
4. Monnet E, Faivre J, Raymond L, et al. Influence of stage at diagnosis on survival differences for rectal cancer in three European populations. Br J Cancer 1999;81:463-8
5. Atkin WS. Options for screening for colorectal cancer. Scand J Gastroenterol Suppl 2003;(237):13-16
6. Tappenden P, Chilcott JB, Eggington S, et al. Option appraisal of population-based colorectal cancer screening in England. Gut 2006, (Epub ahead of press)
7. Jorgensen OD, Kronborg O, Fenger C. A randomised study of screening for colorectal cancer using faecal occult blood testing: results after 13 years and seven biennial screening rounds. Gut 2002;50:29-32
8. Scholefield JH, Moss S, Sufi F, et al. Effect of faecal occult blood screening on mortality from colorectal cancer: results from a randomised controlled trial. Gut 2002;50:840-4
9. Mandel JS, Church TR, Ederer F, et al. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Canc Inst 1999;91:434-7
10. UK Colorectal Cancer Screening Pilot Group. Results of the first round of a demonstration pilot of screening for colorectal cancer in the United Kingdom. BMJ 2004;329:133
11. Hardcastle JD, Chamberlain JO, Robinson MHE, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996;348:1472-7
12. Atkin WS, Cuzick J, Northover JM, et al. Prevention of colorectal cancer by once-only sigmoidoscopy. Lancet 1993;341:736-40
13. Muller AD, Sonnenberg A. Prevention of colorectal cancer by flexible endoscopy and polypectomy. A case-control study of 32,702 veterans. Ann Intern Med 1995;123:904-10
14. Selby JV, Friedman GD, Quesenberry Jr CP, et al. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 1992;326:653-7
15. Newcomb PA, Norfleet RG, Storer BE, et al. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 1992;84:1572- 5
16. Newcomb PA, Storer BE, Morimoto LM, et al. Long-term efficacy of sigmoidoscopy in the reduction of colorectal cancer incidence. J Natl Cancer Inst 2003;95:622-5
17. Atkin WS, Edwards R, Wardle J, et al. Design of a multicentre randomised trial to evaluate flexible sigmoidoscopy in colorectal cancer screening. J Med Screen 2001;8:137-44
18. Segnan N, Senore C, Andreoni B, et al. Baseline findings of the Italian multicenter randomized controlled trial of 'once-only sigmoidoscopy' - SCORE. J Natl Cancer Inst 2002;94:1763-72
19. Weissfeld JL, Schoen RE, Pinsky PF, et al. Flexible sigmoidoscopy in the PLCO cancer screening trial: results from the baseline screening examination of a randomized trial. J Natl Cancer Inst 2005;97:989-97
20. Atkin WS, Hart A, Edwards R, et al. Uptake, yield of neoplasia, and adverse effects of flexible sigmoidoscopy screening. Gut 1998;42:560-565
21. Taylor T, Williamson S, Wardle J, et al. Acceptability of flexible sigmoidoscopy screening in older adults in the United Kingdom. J Med Screen 2000;7:38-45
22. Wardle J, Williamson S, Sutton S, et al. Psychological impact of colorectal cancer screening. Health Psychol 2003;22:54-9
23. Wardle J, Atkin WS. Uptake of flexible sigmoidoscopy screening - reply. Lancet 2002;60:1172-3
24. Liang SY, Phillips KA, Nagamine M, et al. Rates and predictors of colorectal cancer screening. Prev Chron Dis 3;A117:2006
25. Verne JECW, Aubrey R, Love SB, et al. Population based randomised study of uptake and yield of screening by flexible sigmoidoscopy compared with screening by faecal occult blood testing. BMJ 1998;317:182-5
26. McQueen A, Vernon SW, Meissner HI, et al. Are there gender differences in colorectal cancer test use prevalence and correlates? Cancer Epidemiol Biomarkers Prev 2006;15:782-91
27. Wardle J, Miles A, Atkin W. Gender differences in utilization of colorectal cancer screening. J Med Screen 2005;12:20-7
28. Farraye FA, Wong M, Hurwitz S, et al. Barriers to endoscopic colorectal cancer screening: are women different from men? Am J Gastroenterol 2004;99:341-9
29. Varadarajulu S, Petruff C, Ramsey WH. Patient preferences for gender of endoscopists. Gastrointest Endosc 2002;56:170-3
30. Schoenfeld P, Lipscomb S, Crook J, et al. Accuracy of polyp detection by gastroenterologists and nurse endoscopists during flexible sigmoidoscopy: a randomized trial. Gastroenterology 1999;117:312- 18
31. Townsend P, Phillimore P, Beattie A. Health and Deprivation: Inequality and the North. Kent: Croom Helm, 1988
32. Hardcastle JD, Farrands PA, Balfour TW, et al. Controlled trial of faecal occult blood testing in the detection of colorectal cancer. Lancet 1983;2:1-4
33. Senore C, Segnan N, Rossini FP, et al. Screening for colorectal cancer by once only sigmoidoscopy: a feasibility study in Turin, Italy. J Med Screen 1996;3:72-8
34. Miles A, Brotherstone H, Robb KA, et al. Using loss-framed messages to promote adherence to colorectal cancer screening. Annals Behav Med 2005;29:S57
35. Brotherstone H, Miles A, Robb KA, et al. The impact of pictures on public understanding of the aim of cancer screening. Patient Educ Couns 2006;63(3):328-35
36. UK Flexible Sigmoidoscopy Screening Trial Investigators. Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre randomised trial. Lancet 2002;359:1291-300
37. Segnan N, Senore C, Andreoni B, et al. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates. J Natl Cancer Inst 2005;97:347-57
38. Seeff LC, Nadel MR, Klabunde CN, et al. Patterns and predictors of colorectal cancer test use in the adult US population. Cancer 2004;100:2093-103
39. Evans REC, Brotherstone H, Miles A, et al. Gender differences in early detection of cancer. J Men Health Gender 2005;2:209-17
40. Wardle J, McCaffery K, Nadel M, et al. Socioeconomic differences in cancer screening participation: comparing cognitive and psychosocial explanations. Soc Sci Med 2004;59:249-61